Acorda Therapeutics Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 52
- Published: June 2019
- Report Code: MLPH27012FSA
Acorda Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. Its portfolio encomppases marketed products for the treatment of multiple sclerosis (MS) and for the intermittent treatment of people with Parkinson’s taking carbidopa or levodopa who experience off episodes. It is also developing a pipeline of neurological therapies addressing a range of disorders, including migraine, MS, heart failure and spinal cord injury. The company sells its products through wholesale pharmaceutical distributors to retail pharmacies and specialty pharmacy providers. It has subsidiaries in the US and Europe. Acorda is headquartered in Ardsley, New York, the US.
Scope
Detailed information on Acorda Therapeutics Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Acorda Therapeutics Inc in the form of a SWOT analysis
An in-depth view of the business model of Acorda Therapeutics Inc including a breakdown and examination of key business segments
News about Acorda Therapeutics Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Acorda Therapeutics Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Acorda Therapeutics Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Acorda Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Biogen Inc
Amneal Pharmaceuticals Inc
Sandoz International GmbH
AbbVie Inc
Intec Pharma Ltd
Genzyme Corp
Newron Pharmaceuticals SpA
F. Hoffmann-La Roche Ltd
Teva Pharmaceutical Industries Ltd
Merck & Co Inc
Bayer AG
Adamas Pharmaceuticals Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.